Torrent Pharmaceuticals Ltd
Edit

Torrent Pharmaceuticals Ltd

http://www.torrentpharma.com/
Last activity: 31.07.2026
Active
Categories: AcquisitionHealthcareIndiaManufacturingPharmaceuticals
Torrent Pharma, with a market cap of over Rs. 20,000 Cr, is a flagship company of the Torrent Group. It is ranked among the top Pharma Companies of India with many of its products ranking among the top 500 brands (AIOCD Dataset). It is a dominant player in the therapeutic areas of Cardiovascular (CV) and Central Nervous System (CNS) and has achieved significant presence in Gastro-intestinal, Diabetology, Anti-infective and Pain Management segments. It has also forayed into the Oncology and Nephrology segments while also strengthening its focus on Gynaecology and Nutraceuticals segments. Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities located at Indrad and Dahej in Gujarat, Baddi in Himachal Pradesh and Sikkim in North East, advanced R&D capabilities, extensive domestic network and a widespread global presence across 40 countries. The plants are approved by authorities from various regulated and semi regulated markets like US, UK, Brazil, Germany, Australia and South Africa. Right from pioneering niche marketing in India to earning the sobriquet of ‘the Company with the most First Launches’, Torrent Pharma has always remained ahead of its competition.
Likes
46.39K
Followers
177.55K
Website visits
60.5K /mo.
Mentions
45
Location: India
Employees: 10001+
Phone: +91 79 2659 9000
Total raised: $40M
Founded date: 1971

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
02.04.2014-$40M-

Mentions in press and media 45

DateTitleDescription
31.07.2026Torrent Pharma to cut medical representative strength to around 9,000 this year-
30.07.2026Torrent Pharma FYQ1 PAT rises 3.3% as JB integration costs & higher finance charges weigh on earnings-
10.07.2026ChrysCapital’s open offer for Novartis India fails as shares surgeThe Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital’s open offer to acquire additional shares of Novartis India Ltd has found no takers as the drugmaker’s share...
09.07.2026Dr Reddy's delays semaglutide supplies due to API issueMUMBAI: Dr Reddy's Laboratories' plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing the company to cut its exp...
22.05.2026Q4 Results Highlights: Sun Pharma, Shilpa Medicar, Info Edge, Eicher Motors profit up, Hindalco, Torrent Pharma, Colgate profit downBusiness team discuss work analysis with graph data, market growth report, presentation and brainstorming on profit strategy planning, financial investment advisor, company accounting ideas. | Photo Credit: ArLawKa AungTun Q4 Results Today,...
22.05.2026Greater Pacific Capital names Nandan Desai sole India head as co-head leavesNandan Desai, managing director and India head at Greater Pacific Capital Greater Pacific Capital (GPC), the UK-based private equity firm, has overhauled its leadership in India, with Nandan Desai taking over as the head of the India busine...
04.04.2026India’s pharma exports grow 5.6% to $28 billion in April–February FY26-
20.02.2026ChrysCapital inks $159 mn control deal for Novartis India, makes open offerThe Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital has agreed to acquire Swiss pharmaceutical major Novartis AG’s entire stake in its Mumbai-listed unit for Rs...
13.02.2026Q3 Results Today Highlights: NBCC (India), IPCA Lab, NLC Industries Q3 profit up, Alkem Lab shares slump, Rategain & Blue Jet profit fallData Analysis. Pen with business report on financial advisor desk. Concept of business planning , accounting, business analysis,financial planning services. istock photo for BL | Photo Credit: utah778 Q3 Results Today, 13th Feb 2026 Highlig...
21.01.2026Torrent Pharma recognised as new promoter of JB Chemicals; CEO to step down-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In